Molecular subtyping for clinically defined breast cancer subgroups

Breast Cancer Research

Volumn 17, Issue 1, 2015, Pages

  Zhao, Xi ^a,b   Rødland, Einar Andreas ^c   Tibshirani, Robert ^a   Plevritis, Sylvia ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TUMOR MARKER;

ANALYTIC METHOD; ARTICLE; BREAST CANCER; CLINICAL FEATURE; CONTROLLED STUDY; GENE CENTERING; GENETIC ASSOCIATION; GENETIC PROCEDURES; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR TYPING; PREDICTION; TRIPLE NEGATIVE BREAST CANCER; BREAST NEOPLASMS; COHORT ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; INFORMATION PROCESSING; PROCEDURES; PROGNOSIS;

BIOMARKERS, TUMOR; BREAST NEOPLASMS; COHORT STUDIES; DATASETS AS TOPIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR TYPING; PROGNOSIS; RECEPTORS, ESTROGEN;

EID: 84928238652     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-015-0520-4     Document Type: Article

References (20)

1. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747-52.
2. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869-74.
3. Sørlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100:8418-23.
4. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics. 2006;7:96.
5. Perreard L, Fan C, Quackenbush JF, Mullins M, Gauthier NP, Nelson E, et al. Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay. Breast Cancer Res. 2006;8:R23.
6. Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27:1160-7.
7. Prat A, Perou CM. Mammary development meets cancer genomics. Nat Med. 2009;15:842-4.
8. Russnes HG, Navin N, Hicks J, Børresen-Dale AL. Insight into the heterogeneity of breast cancer through next-generation sequencing. J Clin Invest. 2011;121:3810-8.
9. Sørlie T, Borgan E, Myhre S, Vollan HK, Russnes H, Zhao X, et al. The importance of gene-centring microarray data. Lancet Oncol. 2010;11:719-21.
10. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda O, Dunning M, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486:346-52.
11. The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61-70.
12. Benito M, Parker J, Du Q, Wu J, Xiang D, Perou CM, et al. Adjustment of systematic microarray data biases. Bioinformatics. 2004;20:105-14.
13. Borgan E, Sitter B, Lingjærde OC, Johnsen H, Lundgren S, Bathen TF, et al. Merging transcriptomics and metabolomics - advances in breast cancer profiling. BMC Cancer. 2010;10:628.
14. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2011. http://www.R-project.org/ . ISBN 3-900051-07-0.
15. Stanford Center for Cancer Systems Biology. Data integration core. Stanford Medicine. http://ccsb.stanford.edu/research/core.html . Accessed 3 Mar 2015.
16. National Cancer Institute, National Human Genome Research Institute. The Cancer Genome Atlas. Bethesda, MD: National Institutes of Health. http://cancergenome.nih.gov/ . Accessed 3 Mar 2015.
17. Perou CM, Børresen-Dale AL. Systems biology and genomics of breast cancer. Cold Spring Harb Perspect Biol. 2011;3:a003293.
18. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817-26.
19. Filipits M, Rudas M, Jakesz R, Dubsky P, Fitzal F, Singer CF, et al. A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. Clin Cancer Res. 2011;17:6012-20.
20. Prat A, Perou CM. Deconstructing the molecular portraits of breast cancer. Mol Oncol. 2011;5:5-23.